Werner Pehlemann

RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.

Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom.

Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005.

Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria.

Schwartz Pharma AG is a German company.

Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Gruner Böhringer AG engages in the provision of engineering and planning services. It specializes in the areas of infrastructure construction, hydraulic and sanitary engineering, geomatics, geology, and geographic information systems. The company was founded in 1952 and is headquartered in Oberwil, Switzerland.

HMW Innovations AG, founded in 2002, helps investors benefit from German successful company sales of the MIG funds. The company is based in Pullach, Germany and has subsidiaries in Germany. The private company's description highlights their focus on sustainable innovation and invites potential investors to learn more about their offerings. The text is originally in German but has been translated to English.

ams-OSRAM Asia Pacific Pte Ltd. provides sensor solutions. Its products include light and temperature sensors, smart light and power management, sensor interface and 3D sensing. The company was founded by Jyrki Vaino Kalervo Saarinen in 1993 and is headquartered in Singapore.

Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert.

XOLARIS Service Kapitalverwaltungs (XOLARIS Service) is the private equity and venture capital division of the XOLARIS Group. The firm was founded in 2013 by Stefan Klaile. It is headquartered in Munich, Germany, with offices in Hong Kong and Switzerland.

Dnaprint Pharmaceuticals, Inc. develops theranostic genetic drug combinations. The private company is based in Sarasota, FL.

Part of ams-OSRAM AG, Heptagon Oy is a Finnish company that engages in mechanical and process engineering design services. The company is based in Espoo, Finland.

GLG Pharma LLC operates as a biotechnology company. It develops personalized therapies for patients with cancer and other proliferative diseases. The company was founded by Hector J. Gomez, Richard H. Gabriel and Tony Frudakis in 2009 and is headquartered in Jupiter, FL.

Fritsch Fernmeldebau GmbH provides telecommunication services. The private company is based in Dachau, Germany. The CEO of the German company is Jürgen Fritsch.

Hörgeräte ISMA Interessengemeinschaft selbständiger, mittels is a private company based in Sonneberg, Germany. The German company sells medical and orthopedic articles. The CEO of the company is Andreas Fritsch.